Wyeth appoints new vp of communications
MADISON, N.J. Wyeth on Wednesday named Daniel McIntyre, 54, to the position of vice president of corporate communications, reporting to Timothy Cost, senior vice president of corporate affairs.
“Wyeth is in one of the most important periods in its history,” Cost stated. “We are building momentum toward developing new therapies for patients even as we transform our organization for the future. Having Dan now leading our communications team is an important part of our plan to meet new and evolving challenges.”
McIntyre will be responsible for all internal and external communications for the corporation and its three major divisions—pharmaceuticals, consumer health care and animal health—around the world.
Prior to joining Wyeth, McIntyre held a series of senior executive positions in communications and health care. Most recently, he was managing director of the healthcare practice of Fleishman-Hillard International Communications. He previously served in senior level communications and public policy positions for Pharmacia Corporation, Bayer Corporation’s Pharmaceutical Division, the Bristol-Myers Squibb Company, and Hoffmann-La Roche Inc.
An honors graduate of Seton Hall University, McIntyre holds an MPA from Rutgers University. He is a member of the executive committee of the Rutgers University Foundation, and has served on the boards of trustees of Caldwell College, the American Association for World Health, the New England Healthcare Institute and Connecticut United for Research Excellence. He is also a member of the Public Relations Society of America.
Prestige Brands debuts alergy relief gel
IRVINGTON, N.Y. Prestige Brands Holdings is introducing a new kind of therapy for allergy relief across its Chloraseptic and Little Allergies brand families, to be called Allergen Block, Mark Pettie, Prestige chairman and chief executive officer, shared in a recent analyst call.
“There are two clear advantages to this patented innovative technology as compared with current allergy relief products,” he noted. “First, it works outside the body to help prevent allergy symptoms rather than relieve them once they’ve occurred. And second, they’re drug-free, making it appealing not only to current category users but non-users as well.”
Pettie reported that retailer authorizations have been strong as category managers prepare their stores for the coming cough/cold season. “Strong introductory support will begin with a national PR campaign later this month [August] and advertising is scheduled to start in September as retail distribution gains critical mass.”
The product works by creating an electrostatic field that shields a person’s nose from allergens. Suggested retail price is $14.99.
Kleenex improves tissues with extra soothing power
DALLAS, Texas Kimberly-Clark Corporation has announced a North American launch of Kleenex Facial Tissue with Lotion.
The addition to the Kleenex brand lineup boasts a lotion added to enhance the softness of each tissue. Kleenex also said that the new 3-ply tissue is 17 percent stronger than the company’s prior tissue with lotion.
Kim Underhill, president of the North American Family Care Business arm of Kimberly-Clark said, “Kleenex is the leading facial tissue brand because it consistently meets or exceeds consumers’ needs by delivering new innovations to the marketplace. Our newest facial tissue innovation combines a more soothing feeling with the strength desired by so many consumers.”
Kimberly-Clark has said that it plans other brand product line extensions into 2009.